Subject Index Volume 155

Journal of Controlled Release 155 (2011) e10–e12

Contents lists available at ScienceDirect

Journal of Controlled Release j o u r n a l h o m e p a g e : w w w. e l s ev i e r. c o m / l o c a t e / j c o n r e l

Subject Index Volume 155 (2011) Activatable, (155) 152 Ad genome lipoplex, (155) 317 Adeno-virus, (155) 427 Alginate, (155) 418 Angiogenesis, (155) 376 Anticancer micelles, (155) 367 Antisense, (155) 34 Asialoglycoprotein, (155) 34 Atherosclerosis, (155) 211 Bifunctional fusion protein, (155) 386 Biocompatibility, (155) 77 Bioconjugates, (155) 34 Bioconjugation, (155) 326 Biodegradable polymersomes, (155) 282 Biodistribution, (155) 272, (155) 282 Bioequivalence, (155) 262 Biological barriers, (155) 227 Biomaterials, (155) 116 Bioprinting, (155) 193 Bioreducible polymer, (155) 331 Block catiomer, (155) 296 Block copolymer, (155) 449 Blood–brain barrier, (155) 18 Brain tumor targeting, (155) 393 Breast cancer, (155) 427 Burst release, (155) 358 Cancer, (155) 248 Cancer drug delivery, (155) 227 Cancer therapy, (155) 88, (155) 272, (155) 435 Cancer-initiating (stem) cells, (155) 237 Carbon nanotubes, (155) 344 Cardiotoxicity, (155) 272 Catechol, (155) 3 Cationic liposome, (155) 60 Cavitation, (155) 442 Cell delivery vehicle, (155) 193 Cell penetrating peptides, (155) 134 Cell-penetrating, (155) 26 Cell-penetrating peptide, (155) 128 Cellular internalization, (155) 67 Cellular uptake, (155) 218 Ceramic nanoparticles, (155) 344 Chelators, (155) 200 Chemotherapy, (155) 227 Chitosan, (155) 376 Chondroitin sulfate, (155) 296 Circulation half-life, (155) 167 Circulation kinetics, (155) 282

doi:10.1016/S0168-3659(11)00933-3

Coating system, (155) 47 Co-delivery, (155) 60 Collagen, (155) 376 Contrast agent, (155) 11 Controlled release, (155) 376, (155) 409 Core-shell nanoparticle, (155) 152 Cycloamylose, (155) 54 Cyclodextrins, (155) 200 Cyclotides, (155) 134 Cystic fibrosis sputum, (155) 289 DDS, (155) 40 Dendrimer phthalocyanine, (155) 449 Dendrimers, (155) 77, (155) 88, (155) 435 Diclofenac, (155) 159 Diffusion, (155) 409 DNA condensation, (155) 67 DNA toxins, (155) 227 Docetaxel, (155) 262 Doxorubicin, (155) 88, (155) 272, (155) 435, (155) 458 Drug delivery, (155) 96, (155) 144, (155) 167, (155) 272, (155) 442 Drug delivery system, (155) 88, (155) 104 Drug targeting, (155) 248 Drug resistance, (155) 458 Drug–matrix interaction, (155) 409 Dual imaging, (155) 152 Dual labeling, (155) 282 Duplex oligonucleotides, (155) 88 Elastin like polypeptides, (155) 218 Elastin-like polypeptide, (155) 144, (155) 175 Endocytosis, (155) 134 Focused ultrasound, (155) 358 Fokker–Planck equation, (155) 409 Free polyethylenimine, (155) 67 Geldanamycin, (155) 175 Gene, (155) 418 Gene carriers, (155) 47 Gene delivery, (155) 3, (155) 26, (155) 40, (155) 54, (155) 67, (155) 77, (155) 116, (155) 289, (155) 296, (155) 331 Gene therapy, (155) 312 Glycosaminoglycan, (155) 193 Gold nanoparticles, (155) 3, (155) 344 Heart, (155) 376 Heat shock protein 90, (155) 175 Hematopoietic stem cells, (155) 312 Hepatocellular carcinoma, (155) 175

Subject Index Volume 155 (2011)

Hepatocyte, (155) 218 HO-1 inhibitor, (155) 367 HPMA, (155) 303, (155) 326 HSP32, (155) 367 Hyaluronic acid, (155) 47, (155) 104, (155) 193 Hydrogel, (155) 184, (155) 193, (155) 376 Hypersensitivity reactions, (155) 262 Hyperthermia, (155) 175 IL-6, (155) 128 IL-8, (155) 128 Immunotherapy, (155) 184 In vivo, (155) 77 Infection, (155) 159 Inflammation, (155) 128, (155) 159 Inhalable dry particles, (155) 289 Insulin, (155) 386 Interpenetrating network, (155) 119 Intra-carotid administration, (155) 393 Iron oxide, (155) 152 Iron oxide nanoparticles, (155) 11, (155) 393 Knob, (155) 218 Laser light scattering, (155) 67 Layer-by-layer assembly, (155) 159 Liposomes, (155) 418 Liver fibrosis, (155) 326 Liver sinusoidal endothelial cell, (155) 104 Lymphoma, (155) 184 Magnetic field topography, (155) 393 Magnetic nanoparticles, (155) 344 Magnetic resonance imaging, (155) 11 Magnetic targeting, (155) 393 Mannitol, (155) 289 MAPKAP kinase 2, (155) 128 Membrane toxicity, (155) 296 Mesoporous materials, (155) 409 Methoxy-poly(ethylene glycol)-block-poly(D,L-lactide) micelles, (155) 262 Micelles, (155) 96 Microbubbles, (155) 358, (155) 442 Microemulsion, (155) 400 Microparticles, (155) 184 microRNA-145, (155) 427 MRI, (155) 152 Multidrug resistance, (155) 237 Multifunctional nanoparticles, (155) 237 Nanogel, (155) 54 Nanomedicine, (155) 200 Nanoparticles, (155) 211, (155) 218, (155) 289, (155) 312 Nanoscale hydrogels, (155) 119 Nanotechnology, (155) 248 Nanotherapeutics, (155) 272 Nanoxel-PM™, (155) 262 Non-viral gene delivery, (155) 303 Nonviral vectors, (155) 77 Nuclear drug delivery, (155) 227 Nuclear localization, (155) 34 Nuclear localization signal, (155) 26 Oligonucleotide therapy, (155) 427 Oncolytic adenovirus, (155) 317 Optical imaging, (155) 152 Oral delivery, (155) 119 Orthotopic lung tumor model, (155) 317

PEG-ZnPP, (155) 367 Peptide, (155) 26 Peptide copolymer, (155) 303 Peptide nucleic acids, (155) 34, (155) 312 Peptide scaffold, (155) 134 Phage display, (155) 211 Phenylboronic acid, (155) 331 Phospholipase, (155) 54 Photochemical internalization, (155) 458 Photochemical reaction, (155) 449 Photodynamic therapy, (155) 400, (155) 449 Photosensitizer, (155) 449, (155) 458 pH-responsive, (155) 11 pH-responsive polymer, (155) 167 Phthalocyanine, (155) 400 Poly(amido amine), (155) 331 Poly(ethylene glycol)-b-poly(D,L-lactide), (155) 282 Polyethylenimine, (155) 3, (155) 18 Polyion complex, (155) 104 Polyion complex micelle, (155) 449, (155) 458 Poly(lactic-co-glycolic acid), (155) 312 Polymeric binders, (155) 200 Polymeric drugs, (155) 200 Polymeric gene delivery, (155) 18 Polymeric micelle, (155) 11, (155) 104, (155) 248 Polymeric micelles, (155) 272 Polyplex, (155) 303, (155) 331 Polyplex micelle, (155) 296 Prohormone conversion, (155) 386 Proinsulin, (155) 386 Protein delivery, (155) 54, (155) 119 Protein kinase, (155) 40 Protein therapeutics, (155) 167 PSMA aptamer, (155) 435 Quantum dots, (155) 344 RAFT polymerization, (155) 96, (155) 303 Receptor-mediated endocytosis and recycling, (155) 386 Reduction-sensitive, (155) 96 Responsive hydrogels, (155) 119 RGD peptide, (155) 47 Rho associated coiled-coil kinase, (155) 40 RNAi, (155) 427 RVG peptide, (155) 18 Scaffold, (155) 418 siRNA, (155) 3, (155) 60, (155) 184 Skin cancer, (155) 400 Skin penetration enhancement, (155) 400 SMA-ZnPP, (155) 367 Stabilin-2, (155) 211 2-step system, (155) 442 Suberoylanilide hydroxamic acid, (155) 60 Surface charge, (155) 282 Sustained drug release, (155) 248 Synthetic extracellular matrix, (155) 193 Systemic delivery, (155) 317 Targeted chemoimmunotherapy, (155) 435 Targeting, (155) 47, (155) 211 TFO, (155) 326 T-helper, (155) 184 Theranostics, (155) 344 Thermally responsive polymer, (155) 144 Thermosensitive liposomes, (155) 442 Thymosin β4, (155) 376 TNF-α, (155) 128

e11

e12

Transferrin, (155) 386 Triggered drug delivery, (155) 358 Trilysinoyl oleylamide, (155) 60 Triplex forming oligonucleotides, (155) 312 Tumor, (155) 144 Tumor (ablative) margin, (155) 175 Tumor hypoxia, (155) 237

Subject Index Volume 155 (2011)

Ultrasound, (155) 442 Ultrasound triggered release, (155) 358 Vaginal delivery, (155) 418 Vancomycin, (155) 159 Warburg's effect, (155) 237